Skip to content

The comparison of different types of fluid therapy in prevention of contrast induced renal malfunction in coronary angiography

The comparison of normal saline, ringer lactate and sodium bicarbonate for prevention of contrast induced nephropathy in the patients who underwent coronary angiography in Shiraz

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015080323483N1
Enrollment
300
Registered
2016-10-21
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast induced nephropathy. Nephropathy induced by other drugs, medicaments and biological substances

Interventions

Intervention 1: Intervention 1: In this group, the patients receive intravenous normal saline (0.9%) at a rate of 3 ml/kg one hour before angiography and 1 ml/kg per hour for 6 hours after angiography
Prevention
Intervention 1: In this group, the patients receive intravenous normal saline (0.9%) at a rate of 3 ml/kg one hour before angiography and 1 ml/kg per hour for 6 hours after angiography.
Intervention 2: In this group, the patients receive intravenous ringer lactate at rate of 3 ml/kg one hour before angiography and 1 ml/kg per hour for 6 hours after angiography.
Intervention 3: In this group, the patients receive intravenous sodium bicarbonate (850 ml DW 5% plus 150 mEq sodium bicarbonate) at a rate of 3 ml/kg one hour before angiography and 1 ml/kg per hour

Sponsors

vice chancellor for research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients over 18 y/o who have indications for coronary angiography and angioplasty are included. However, patients with hemodynamic instability, severe cardiac failure or pulmonary edema, under dialysis, under medications potentially affecting kidney function or with electrolyte and acid-base disturbances are not included. Exclusion criteria: patients with undesired complications such as arterial dissection during angiography or angioplasty are excluded from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Creatinine. Timepoint: before and 48 hours after intervention. Method of measurement: Jaffe with adsorbent (picrate) method.;BUN. Timepoint: before and 48 hours after intervention. Method of measurement: urease/GLDH method.;Urine PH. Timepoint: before and 6 hours after intervention. Method of measurement: PH meter sticks.;Estimated GFR (eGFR). Timepoint: before and 48 hours after intervention. Method of measurement: MDRD equation.

Secondary

MeasureTime frame
Sodium and Potassium (Na and K). Timepoint: before and 48 hours after intervention. Method of measurement: flame photometry method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. M. Pakfetrat

Shiraz University of Medical Sciences

pakfetratm@sums.ac.ir00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026